F4 FundFund
TeamPortfolioRaiseEssays
Sign in
Investment ThesisInvestment TeamF4 Research BriefSelected PortfolioRecent UpdatesFrequent co-investors
Active Fund

Legend Capital

legendcapital.com.cn · Beijing, China

Investment thesis

Early, new, hard, big, difficult, long: invest in China's hard technology, AI, healthcare and new-energy leaders with proactive post-investment value-add.

Leads & Follows
Lead Tendency
$10B
AUM
01Investment Thesis

Early, new, hard, big, difficult, long: invest in China's hard technology, AI, healthcare and new-energy leaders with proactive post-investment value-add.

02Investment Team
ZL
Zhu Linan
Chairman
CH
Chen Hao
Vice Chairman
LJ
Li Jiaqing
President / Executive Committee Member
ZH
Zhou Hongbin
COO / Executive Committee Member
WJ
Wang Junfeng
Co-CIO / Executive Committee Member
CR
Chen Rui
Co-CIO / Executive Committee Member
GX
Ge Xinyu
Co-CIO / Executive Committee Member
OH
OuYang Hao
General Legal Counsel / Executive Committee Member
JS
Joon Sung Park
Co-CIO
FJ
Fu Junhua
Managing Director
FQ
Fan Qihui
Managing Director
HT
Hong Tan
Managing Director
JH
Ji Haiquan
Managing Director
TJ
Tang Jie
Managing Director
WJ
Wang Jianfei
Managing Director
WW
Wang Wenlong
Managing Director
WY
Wen Yanbin
Managing Director
XL
Xue Long
Managing Director
ZN
Zhang Nan
Managing Director
ZQ
Zhou Quan
Managing Director
03F4 Research Brief

Legend Capital Research

Investment Thesis

Legend Capital (君联资本) is one of China's oldest and largest venture capital and private equity firms. It was founded in April 2001 as the investment arm of Legend Holdings, the Lenovo parent, and is headquartered in Beijing. The firm describes itself as a leading VC and PE investor in early-stage and growth-stage opportunities in China. Its stated strategy is "early, new, hard, big, difficult, long" (早新硬、大难长): early-stage technology, new industries, hard technology, large markets, difficult problems and long time horizons. Its methodology is "Business First, People Crucial" plus proactive value-added services to portfolio companies. Core value: "Pursuing Fortune of Value". President Li Jiaqing writes that investors must shift from "hunters" to "farmers" who cultivate the technology-innovation ecosystem, and that China's equity market is undergoing a paradigm shift toward RMB funds, state capital and "new quality productivity".

Sector Focus

Legend Capital organizes its portfolio into Technology, Consumption and Healthcare, with a logistics and supply chain list on its English site. The official Chinese site stresses hard tech, AI, quantum computing, biomedicine, semiconductors, intelligent manufacturing, new energy and enterprise services.

  • Technology: new energy and batteries (CATL, CNGR, RKP, Makesense), autonomous driving and AI compute (Pony.ai, Horizon Robotics, LEADRIVE), hydrogen (Refire), retail tech (Hanshow)
  • Consumption: Bilibili, Youdao, Atour, Gambol Pet Group, Bloks Group, Tuhu, ZKH
  • Healthcare: Pharmaron, WuXi AppTec, WuXi Biologics, KingMed, Innovent, Harbour BioMed
  • Logistics: JD Logistics, SF Express, Renrui, KNX and others

Stage Focus

Early-stage venture and growth-stage private equity. The firm runs both US dollar and RMB funds, including dedicated healthcare funds (a USD 250M third healthcare fund) and a Social Security Fund Zhongguancun special innovation fund. Specific check sizes are not published on the website.

Check Size

Not disclosed. Given more than USD 10 billion of commitments across about 700 portfolio companies, checks range from early-stage rounds in the low millions to large growth-stage commitments. This is inferred, not stated by the firm.

Lead Tendency

Third-party reports describe Legend leading rounds (for example a nearly CNY 200 million Series C), and it also co-invests heavily at growth stage. Lead tendency is therefore recorded as both.

Recent Activity

  • January 2026: two portfolio companies listed on the same day, described by the firm as validation of its "early, new, hard, big, difficult, long" strategy and of the Social Security Fund Zhongguancun special fund.
  • September 2026: portfolio company Benmo Technology (本末科技), invested in 2025 in embodied AI and AI, listed on the Hong Kong Stock Exchange.
  • The firm reports 134 IPOs to date, nearly 200 unicorns and about 200 further exits by other routes.

Portfolio Highlights

About 700 companies in total, with 129 to 134 listed. Notable names include CATL, Pony.ai, Horizon Robotics, Bilibili, WuXi AppTec, WuXi Biologics, Innovent, JD Logistics, SF Express, Pharmaron and Hanshow.

Team

  • Zhu Linan, Chairman
  • Chen Hao, Vice Chairman
  • Li Jiaqing, President and Executive Committee Member
  • Zhou Hongbin, COO and Executive Committee Member
  • Wang Junfeng, Co-CIO and Executive Committee Member
  • Chen Rui, Co-CIO and Executive Committee Member
  • Ge Xinyu, Co-CIO and Executive Committee Member
  • OuYang Hao, General Legal Counsel
  • Joon Sung Park, Co-CIO
  • Managing Directors: Fu Junhua, Fan Qihui, Hong Tan, Ji Haiquan, Tang Jie, Wang Jianfei, Wang Wenlong, Wen Yanbin, Xue Long, Zhang Nan, Zhou Quan

Decision Process

Partnership with an executive committee and multiple Co-CIOs. Warm introductions are likely helpful but the firm accepts inbound business plans via its website, with a confidentiality disclaimer.

Founder Preferences

Founders in China (or with operations substantially in China) building hard-technology, AI, healthcare and enterprise businesses with long-term compounding potential. The firm emphasizes the team ("People Crucial") and sustained post-investment support.

Geographic Focus

China first. Offices in Beijing, Shanghai, Shenzhen, Hong Kong, Seoul and Singapore. Overseas investments are made with substantial China operations. Offices outside China suggest selective regional reach in Korea and Southeast Asia.

Gaps

The homepage and portfolio page of legendcapital.com.cn timed out through the captioned reader; the English site (legendcapitalco.com) was read instead, and the portfolio lists were pulled from the site's own category endpoint. Check sizes, current fund status and per-company stage and dates are not published.

04Selected Portfolio
Aerospace & Defense
Dookbook
Biotech & Life Sciences
Pharmaron·WuXi PharmaTech·WuXi Biologics·Innovent·Harbour Biomed·Baheal Pharma Group
Climate & Sustainability
YONZ TECHNOLOGY·REFIRE
E-commerce & Marketplaces
ZKH
EdTech
Youdao
Energy & Power
CATL
Enterprise Software
Hanshow·MakeSense·KNX
Food & Beverage
RKP·GAMBOL PET GROUP
Gaming
Bloks Group
Healthcare & Digital Health
KingMed·Yixintang·Aohua Endoscopy·Aidite
HR Tech & Future of Work
Renrui
Logistics & Supply Chain
JD Logistics·China Eastern Airlines Logistics·Milkyway Chemical Supply Chain Service Co., LTD·HICHAIN logistics·China Southern Air Logistics·Shuhai supply chain·SF Express·SF cityrush
Manufacturing & Industrial
TECHSTORM
Marketing & Adtech
Qunabox Group
Media & Entertainment
Bilibili
Mobility & Transportation
Horizon Robotics·Pony.ai·LEADRIVE TECHNOLOGY·Tuhu
Security & Cybersecurity
JWM
Semiconductors & Hardware
CNGR
Travel & Hospitality
Atour
Open the full portfolio→
05Recent Updates

Fresh signals from public announcements, essays, and portfolio activity.

Portfolio company Benmo Technology, invested in 2025, listed on the Hong Kong Stock Exchange.
EXIT·legendcapital.com.cn
SEP 2026
Two portfolio companies listed on the same day, funded partly through the Social Security Fund Zhongguancun special fund.
EXIT·legendcapital.com.cn
JAN 2026
06Frequent co-investors
5C
5Y Capital
Both backed 2 of the same companies
Horizon Robotics, Pony.ai
AB
Ally Bridge Group
Both backed 2 of the same companies
WuXi PharmaTech, WuXi Biologics
SH
Sherpa Healthcare Partners
Both backed 2 of the same companies
WuXi Biologics, Innovent
Find the investors for your round→
Quick Reference
Stages
Seed · Series A · Series B · Growth
AUM
$10B
Decision
Investment Committee
Location
Beijing, China
Sector Focus
E-Commerce & MarketplacesBiotech & Life SciencesSemiconductors & HardwareLogistics & Supply ChainMobility & TransportationEnterprise SoftwareEnergy & PowerHealthcare & Digital Health
Models
Hard TechHealthcareConsumerEnterprise Services
Technology
AI/MLSemiconductorsNew EnergyAutonomous Driving
See all E-commerce & Marketplaces investors →See all Biotech & Life Sciences investors →See all Semiconductors & Hardware investors →
Visit legendcapital.com.cn ↗

See how Legend Capital matches your startup

Get a personalized match report in minutes.

Get Your Match Report
Focus Areas
E-Commerce & MarketplacesBiotech & Life SciencesSemiconductors & HardwareLogistics & Supply ChainMobility & TransportationEnterprise SoftwareEnergy & PowerHealthcare & Digital Health

See how Legend Capital matches your startup

Get a personalized match report in minutes.

Get Your Match Report
Is this your firm? Claim your profile
F4 Intelligence Report · Last Researched November 6, 2026F4 Research Engine